Results 251 to 260 of about 1,661,955 (279)

Regulatory Framework for Cell and Tissue Based Therapies in Europe

2016
Whereas some basic therapies based on tissues and cells have been in clinical use for years, advances in regenerative medicine present new challenges and new types of products for regulation. This article focuses on cell therapies which can be classified as medicinal products across the European Union.
Gudrun Tiedemann, Sebastian Sethe
openaire   +1 more source

Regulatory Frameworks for Cell and Tissue Based Therapies in Europe and the USA

2010
Whereas some basic therapies based on tissues and cells have been in clinical use for years, regulatory regimes applying to such applications have recently been revised and extended in Europe and in the US. Moreover, advances in regenerative medicine present new challenges and new types of products for regulation.
Gudrun Tiedemann, Sebastian Sethe
openaire   +1 more source

Tissue-based Gene Expression Diagnosis of Mild and Moderate T-cell-mediated Rejection to Guide Therapy in Kidney Transplants

Transplantation
Background. Mild histologic lesions of tubulo-interstitial inflammation could represent a “response-to-wounding” rather than allorecognition. Tissue gene expression may complement histopathology for T-cell-mediated rejection (TCMR) diagnostics. Methods.
Dhiren, Kumar, Nihar, Raju, Bekir, Tanriover, Louiza, Azzouz, Irfan, Moinuddin, Mary, Philogene, Layla, Kamal, Felecia, McDougan, Hugh Davis, Massey, Selvaraj, Muthusamy, Inkoo, Lee, Philip, Halloran, Gaurav, Gupta   +12 more
openaire   +2 more sources

A Narrative Review on Efficacy of Cell‐ and Tissue‐Based Therapies for Diabetic Foot Ulcer

Advanced Therapeutics
AbstractDiabetic foot ulcers (DFUs) are complex, making conventional treatments challenging in restoring skin tissue. Stem cell therapy (SCT) and skin replacement therapy (SRT) offer promising solutions by addressing prolonged inflammation, impaired cell proliferation, and reduced extracellular support.
Behnaz Niroomand, Ibrahim Mohammadzadeh, Maryam Tabarzad, Elham Mohit   +3 more
openaire   +1 more source

Cell- and tissue-based therapies for lung disease

2020
Jeffrey A. Whitsett, William Zacharias, Daniel Swarr, Vladimir V. Kalinichenko   +3 more
openaire   +1 more source

Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies

Journal of Wound Care, 2018
Piaggesi, Alberto, Låuchli, Severin, Bassetto, Franco, Biedermann, Thomas, Marques, Alexandra, Najafi, Bijan, Palla, Ilaria, Scarpa, Carlotta, Seimetz, Diane, Triulzi, Isotta, Turchetti, Giuseppe, Vaggelas, Annegret   +11 more
openaire   +3 more sources

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

〈1046〉 Cell-Based Advanced Therapies and Tissue-Based Products

2021
openaire   +1 more source

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly